(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the U.S. launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, a therapeutic equivalent generic version of Librax.

Dr. Reddy’s generic product is supplied i n a strength of 2.5 mg/1000 mg in a bottle count of 60 and strengths of 5 mg/500 mg and 5 mg/1000 mg, each in bottle counts of 30.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY), on Saturday, announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. Dr. Reddy's said Sapropterin ...

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market. September 02, 2021 12:12 AM Eastern Daylight Time.

Indian drugmaker Dr. Reddys Laboratories (RDY) said it has launched a generic equivalent of AstraZeneca's (AZN) diabetes medication Kombiglyze XR for the US market. Read more here.

MUMBAI, Nov 24 (Reuters) - Dr Reddy's Laboratories Ltd on Monday said it launched the authorised generic version of GlaxoSmithKline's Imitrex tablets in the U.S. market. The Indian firm has ...

[Read more: Dr. Reddy’s to acquire Mayne Pharma’s U.S. generic portfolio] Dr. Reddy's treprostinil injection is supplied as 20 mg/20 ml, 50 mg/20 ml, 100 mg/20 ml or 200 mg/20 ml vials.